NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 701–800 of 1,014
Mashrur, M. N., Hoque, M. N., Hasnat, S., Saikat, S. H., Hasan, M. M., Hridy, F. K., Rani, N. A., & Azam, F. M. S. (2025) · Vacunas (English Edition) · doi:10.1016/j.vacun.2025.500461 · Cited by 13
Ehsasatvatan, M., Kohnehrouz, B. B., & Salavatizadeh, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11339-x · Cited by 13
Kessler, A. L., Fort, K. L., Resemann, H. C., Krüger, P., Wang, C., Koch, H., Hauschild, J.-P., Marino, F., & Heck, A. J. R. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101049 · Cited by 13
Huang, S., He, Y., Madow, A., Peng, H., Griffin, M., Qi, J., Huang, M., Amoroso, H., Abrashoff, R., Heldman, N., et al. (2025) · Advanced Materials · doi:10.1002/adma.202510229 · Cited by 13
Applications of artificial intelligence and nanotechnology in vaccine development
Bahrami, Y., Bolideei, M., Mohammadzadeh, S., Gahrouei, R. B., Mohebbi, E., Haider, K. H., Barzigar, R., & Mehran, M. J. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126096 · Cited by 13
An, Y., Ali, S. L., Liu, Y., Abduldayeva, A. A., Ni, R., Li, Y., Zhang, M., Tian, Y., Jiang, L., & Gong, W. (2025) · Biology · doi:10.3390/biology14091196 · Cited by 13
Li, C., Zhu, Y., Qi, X., Chai, Z., Luo, J., Shang, K., Tian, T., Shi, H., Li, M., Xu, R., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334843 · Cited by 13
Zhao, H., Cheng, Y., Zhang, T., Wang, Q., Xu, Y., Wang, G., Song, Y., Chen, H., Wu, Y., Zhang, M., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01199-0 · Cited by 13
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion
Chemla, Y., Itzhaki, O., Melamed, S., Weller, C., Sade, Y., Manich, P., Reshef, K., Xenidis, N., Maliah, A., Levy, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.020 · Cited by 13
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
Foix, A., López, D., Díez‐Fuertes, F., McConnell, M. J., & Martín-Galiano, A. J. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009726 · Cited by 13
Dieng, C. C., Ford, C. T., Lerch, A., Donu, D., Huynh, J., Vegesna, K., Guo, J., Janies, D. A., Amoah, L. E., Afrane, Y. A., et al. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105418 · Cited by 13
The ER folding sensor UGGT1 acts on TAPBPR-chaperoned peptide-free MHC I
Sagert, L., Winter, C., Ruppert, I., Zehetmaier, M., Thomas, C., & Tampé, R. (2023) · eLife · doi:10.7554/elife.85432 · Cited by 13
Naveed, M., Mehmood, S., Aziz, T. A., Arif, M. H., Ali, U., Nouroz, F., Zacharis, C., Alharbi, M., Alshammari, A., & Alasmari, A. F. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6721 · Cited by 13
Kim, K., Kim, H. M., Shin, I., Noh, S.-J., Kim, J. Y., Suh, K. J., Kim, Y.-N., Lee, J., Cho, D.-Y., Kim, S. H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-49639-4 · Cited by 13
Miao, C., Cui, Y., Li, Y., Qi, Q., Shang, W., Chen, H., Gao, Y., Yuan, R., Long, Q., Wu, W., et al. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s441302 · Cited by 13
A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from Penicillium cerradense
Andrade, K. C. R., Homem-de-Mello, M., Motta, J. A., Guimarães, M. B., de Abreu, J. A. C., Souza, P. M., Pessoa, A., Pappas, G. J., Jr., & Magalhães, P. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094788 · Cited by 13
An immunoinformatic approach for developing a multi-epitope subunit vaccine against Monkeypox virus
Nayak, A. K., Chakraborty, A., Shukla, S., Kumar, N., & Samanta, S. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00220-5 · Cited by 13
Sears, T. J., Pagadala, M. S., Castro, A., Lee, K.-H., Kong, J., Tanaka, K., Lippman, S. M., Zanetti, M., & Carter, H. K. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0164 · Cited by 13
Machine learning optimization of peptides for presentation by class II MHCs
Dai, Z., Huisman, B. D., Zeng, H., Carter, B., Jain, S., Birnbaum, M. E., & Gifford, D. K. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab131 · Cited by 13
de Vrij, N., Meysman, P., Gielis, S., Adriaensen, W. J., Laukens, K., & Cuypers, B. (2021) · Vaccines · doi:10.3390/vaccines9030270 · Cited by 13
Junet, V., & Daura, X. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab687 · Cited by 13
Nguyen, T. L., Lee, Y. H., & Kim, H. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10382-5 · Cited by 13
Epitope-Evaluator: An interactive web application to study predicted T-cell epitopes
Soto, L. F., Requena, D., & Bass, J. I. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273577 · Cited by 13
Connelley, T., Nicastri, A., Sheldrake, T. A., Vrettou, C., Fisch, A., Reynisson, B., Buus, S., Hill, A. V. S., Morrison, I. W., Nielsen, M., et al. (2022) · Vaccines · doi:10.3390/vaccines10111907 · Cited by 13
Self-citationSharma, A. D., Grewal, R. K., Gorle, S., Orduz, A. F. C., Kaushik, V., Shaikh, A. R., Cavallo, L., & Chawla, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2226721 · Cited by 13
Refsgaard, C. T., Barra, C., Peng, X., Ternette, N., & Nielsen, M. (2021) · ImmunoInformatics · doi:10.1016/j.immuno.2021.100005 · Cited by 12
Self-citationOthoum, G., & Maher, C. A. (2023) · NAR Cancer · doi:10.1093/narcan/zcad024 · Cited by 12
Systems immunology spanning tumors, lymph nodes, and periphery
Sidiropoulos, D. N., Ho, W. J., Jaffee, E. M., Kagohara, L. T., & Fertig, E. J. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100670 · Cited by 13
Sira, E. M. J. S., Fajardo, L. E., Banico, E. C., Odchimar, N. M. O., & Orosco, F. L. (2025) · Veterinary Medicine International · doi:10.1155/vmi/2638167 · Cited by 12
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
Kuras, M., Betancourt, L. H., Hong, R., Szadai, L., Murillo, J. R., Horvatovich, P. L., Plá, I., Eriksson, J. O., Szeitz, B., Deszcz, B., et al. (2025) · Cancers · doi:10.3390/cancers17050832 · Cited by 12
Willems, P., Théry, F., Moortel, L. V., Meyer, M. D., Staes, A., Gul, A., Kovalchuke, L., Declercq, A., Devreese, R., Bouwmeester, R., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00864 · Cited by 12
Garde, C., Pavlidis, M. A., Garces, P., Lange, E. J., Ramarathinam, S. H., Sokač, M., Pandey, K., Faridi, P., Ahrenfeldt, J., Chung, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01107-y · Cited by 12
Salzler, R. R., DiLillo, D. J., Saotome, K., Bray, K., Mohrs, K., Hwang, H., Cygan, K. J., Shah, D., Rye-Weller, A., Kundu, K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ado9371 · Cited by 12
Nikopaschou, M., Samiotaki, M. K., Stylianaki, E.-A., Król, K., Gragera, P., Raja, A., Aidinis, V., Chroni, A., Fruci, D., Panayotou, G., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100964 · Cited by 12
Ullah, S., Ullah, H., Fatima, K., & Tan, L. (2025) · Veterinary Sciences · doi:10.3390/vetsci12060577 · Cited by 12
Zhou, P., Shi, X., Xia, J., & Hu, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1611991 · Cited by 12
Agarwal, R., Ha, C., Côrtes, F. H., Lee, Y. J., Martínez-Pérez, A., Gálvez, R. I., Castillo, I. N., Phillips, E. J., Mallal, S. A., Balmaseda, Á., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60862-7 · Cited by 12
Zenga, J., Awan, M. J., Frei, A. C., Foeckler, J., Kuehn, R., Kasprzak, J., Massey, B. L., Bruening, J., Akakpo, K. E., Shukla, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60827-w · Cited by 12
Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer
Bryant, J. M., Ruffolo, L. I., Soares, K. C., Hoffe, S. E., & Lowy, A. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191944 · Cited by 12
Tombari, W., Khamessi, O., Othman, H., Kallala, O., Mahjoub, R., Ghedira, K., & Trabelsi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-16143-w · Cited by 12
Shi, Y., Jiao, Q., Hu, X., & Jia, T. (2025) · Biotechnology Journal · doi:10.1002/biot.70120 · Cited by 12
Shatalov, P. A., Bukaeva, A. A., Veselovsky, E., Traspov, A. A., Багдасарова, Д. В., Leukhina, I. A., Shinkarkina, A. P., Raygorodskaya, M. P., Murzaeva, A. V., Mechenici, Y. A., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092213 · Cited by 12
Predictive and therapeutic applications of protein language models.
Furui, K., Sakano, K., & Ohue, M. (2025) · Allergology International · doi:10.1016/j.alit.2025.08.004 · Cited by 10
Sahoo, S., Lee, H., & Shin, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-19826-6 · Cited by 12
Chai, Z., Qi, X., Li, R., Luo, J. L., Li, C., Shi, H., Tian, T., Shang, K., Zhu, Y., & Zhang, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-20507-7 · Cited by 12
PredIG: an interpretable predictor of T-cell epitope immunogenicity
Farriol-Duran, R., Domínguez-Dalmases, C., Cañellas-Solé, A., Vázquez, M., Porta‐Pardo, E., & Guallar, V. (2025) · Genome Medicine · doi:10.1186/s13073-025-01569-8 · Cited by 12
Delaunay, A. P., McGibbon, M., Djermani, B. A., Gorbushin, N., García-Mascaraque, S. C., Rayment, I., Kizhvatov, I., Petit, C., Lang, M., Beguir, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26454-7 · Cited by 12
Alternative splicing: from tumorigenesis to neoantigen-mediated cancer immunotherapy
Lv, Y., He, Y., Dai, X.-Y., Yang, X., Cai, Y., Luo, R., Xie, Q., Xie, S., Chen, X., Zhou, Q., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00877-w · Cited by 12
Fu, Z., Song, Y., Liu, F., Chen, L., Cai, S., Cui, P., Wang, G., Xie, W., Zhang, S., Ding, L., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2025.12.014 · Cited by 12
Tang, Z., Zha, L., Liang, R., & Li, T. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01778-7 · Cited by 12
TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how
Nose, Y., Figueiredo, I., Tuballes, K., Valle, D. M. D., Gonsalves, T. R., Guo, R., Ioannou, G., Cabal, R., Gonzalez‐Kozlova, E., & Gnjatic, S. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013499 · Cited by 12
Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
Bose, T., Pant, N., Pinna, N. K., Bhar, S., Dutta, A., & Mande, S. S. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198579 · Cited by 12
Teahan, B., Ong, E., & Yang, Z. (2021) · Vaccines · doi:10.3390/vaccines9101098 · Cited by 12
Reverse vaccinology approach to design a vaccine targeting membrane lipoproteins of Salmonella typhi
Sharma, S., Solanki, V., & Tiwari, V. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2015443 · Cited by 12
Trevizani, R., & Custódio, F. L. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100038 · Cited by 12
Soto, L. F., Romaní, A. C., Jiménez-Avalos, G., Díaz, Y. A. S., Ramírez, C., Lapa, R. M. L., & Requena, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.942907 · Cited by 12
A candidate multi‐epitope vaccine against Lumpy skin disease
Uddin, M. B., Tanni, F. Y., Hoque, S. F., Sajib, E. H., Faysal, M. A., Rahman, M. A., Galib, A., Emon, A. A., Hossain, M. M., Hasan, M., et al. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14718 · Cited by 12
Hydrophobicity identifies false positives and false negatives in peptide-MHC binding
Solanki, A., Riedel, M. D., Cornette, J. L., Udell, J. B. M., & Vasmatzis, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1034810 · Cited by 12
Huisman, B. D., Balivada, P. A., & Birnbaum, M. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102913 · Cited by 12
Fritah, H., Graciotti, M., Chiang, C. L.-L., Huguenin-Bergenat, A.-L., Pétremand, R., Ahmed, R., Guillaume, P., Schmidt, J., Stevenson, B. J., Gfeller, D., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106288 · Cited by 12
Gunasekera, D., Vir, P., Karim, A. F., Ragni, M. V., & Pratt, K. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128641 · Cited by 12
Bodas-Pinedo, A., Lafuente, E. M., Pelaez-Prestel, H. F., Ras-Carmona, A., Subiza, J. L., & Reche, P. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235053 · Cited by 12
Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses
van Bergen, J., Camps, M. G. M., Pardieck, I. N., Veerkamp, D. M. B., Leung, W. Y., Leijs, A. A., Myeni, S. K., Kikkert, M., Arens, R., Zondag, G. C. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.172488 · Cited by 12
Zhan, Y., Ye, L., Ouyang, Q., Yin, J., Cui, J., Liu, K., Guo, C., Zhang, H., Zhai, J., Zheng, C., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29113 · Cited by 12
Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection
Dravid, P., Murthy, S. S., Attia, Z., Cassady, C., Chandra, R., Trivedi, S., Vyas, A. K., Gridley, J., Holland, B., Kumari, A. R., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011697 · Cited by 12
Elalouf, A., Kedarya, T., Elalouf, H., & Rosenfeld, A. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00574-x · Cited by 12
Choudhury, A., Chandra, A., Dawoud, T. M. S., Nafidi, H., Singh, N., & Bourhia, M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1295817 · Cited by 12
Porcheddu, V., Lhomme, G., Giraudet, R., Correia, E., & Maillère, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345195 · Cited by 12
Pathak, R. K., & Kim, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae025 · Cited by 12
Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants
Deng, S., Xu, Z., Wang, M., Hu, J., Liu, Z., Zhu, F., Zheng, P., Kombe, A. J. K., Zhang, H., Wu, S., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107563 · Cited by 12
Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses
Oladipo, E. K., Oyelakin, O. D., Aiyelabegan, A. O., Olajide, E. O., Olatayo, V. O., Owolabi, K. P., Shittu, Y. B., Olugbodi, R. O., Ajala, H. A., Rukayat, R. A., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1360 · Cited by 12
In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines
Pillay, K., Chiliza, T. E., Senzani, S., Pillay, B., & Pillay, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37536 · Cited by 12
Tscherne, A., Kalodimou, G., Kupke, A., Rohde, C., Freudenstein, A., Jany, S., Kumar, S., Sutter, G., Krähling, V., Becker, S., et al. (2024) · Vaccines · doi:10.3390/vaccines12121316 · Cited by 12
Wei, M., Liang, S., Wang, Y., Hu, J., & Pang, F. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106296 · Cited by 12
Lehmann, A. A., Zhang, T., Reche, P. A., & Lehmann, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618428 · Cited by 12
A Multi-Epitope Chitosan Nanoparticles Vaccine ofCanine AgainstEchinococcus granulosus
Li, Y., Zhu, Y., Sha, T., Chen, Z., Yu, M., Zhang, F., & Ding, J. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3065 · Cited by 12
A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
Martin, P. J., Levine, D., Storer, B. E., Zheng, X., Jain, D., Heavner, B., Norris, B. M., Geraghty, D. E., Spellman, S. R., Sather, C. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.782152 · Cited by 12
Naive and memory T cells TCR–HLA-binding prediction
Glazer, N., Akerman, O., & Louzoun, Y. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac001 · Cited by 12
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
Kehl, N., Kilian, M., Michel, J., Wagner, T. R., Uhrig, S., Brobeil, A., Sester, L. S., Blobner, S., Steiger, S., Hundemer, M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005815 · Cited by 12
Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
Papadaki, G. F., Ani, O., Florio, T. J., Young, M. C., Danon, J. N., Sun, Y., Dersh, D., & Sgourakis, N. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1116906 · Cited by 12
Potential global impact of the N501Y mutation on MHC-II presentation and immune escapePreprint
Castro, A., Carter, H. K., & Zanetti, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.02.429431 · Cited by 12
Dolley, A., Goswami, H. B., Dowerah, D., Dey, U., Kumar, A. A., Hmuaka, V., Mukhopadhyay, R., Kundu, D., Varghese, G. M., Doley, R., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23616 · Cited by 11
RNA splicing junction landscape reveals abundant tumor-specific transcripts in human cancer
Li, Q., Li, Z., Chen, B., Zhao, J., Yu, H., Hu, J. N., Lai, H., Zhang, H., Li, Y., Meng, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114893 · Cited by 11
Toward equitable major histocompatibility complex binding predictions
Glynn, E., Ghersi, D., & Singh, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405106122 · Cited by 11
Revolutionizing Chikungunya Vaccines: mRNA Breakthroughs With Molecular and Immune Simulations
Masum, M. H. U., Mahdeen, A. A., & Barua, A. (2025) · Bioinformatics and Biology Insights · doi:10.1177/11779322251324859 · Cited by 11
Associations between HLA-II variation and antibody specificity are predicted by antigen properties
Innocenti, G., Andreu‐Sánchez, S., Hörstke, N. V., ElAbd, H., Barozzi, I., Franke, A., Manczinger, M., & Vogl, T. J. (2025) · Genome Medicine · doi:10.1186/s13073-025-01486-w · Cited by 11
Cho, S., Kwak, W., Yoon, H., Lee, J., Lee, S., Park, H., Jo, S., Lee, Y., Seo, Y., Cho, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202506426 · Cited by 11
Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy
Shibata, H., Kuroki, M., Kawaura, R., Yamada, T., Iinuma, R., Ishihara, H., Okuda, H., Mori, K., & Ogawa, T. (2025) · Cancer Science · doi:10.1111/cas.70176 · Cited by 11
Lee, K.-H., Sears, T. J., Zanetti, M., & Carter, H. K. (2026) · Nature Communications · doi:10.1038/s41467-026-68651-6 · Cited by 11
Mamoudou, H., & Alain, M. M. M. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100322 · Cited by 11
AI-powered mapping of tumor immunity for optimized mRNA vaccine engineering
Srivastava, R. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1766201 · Cited by 11
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome
Vendramin, R., Fu, H., Patel, S. F., Zhao, Y., Qian, D., Ligammari, L., Bartok, O., Greenberg, P., Levy, R., Castro, A., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.02.005 · Cited by 11
Rowaiye, A. B., Oli, A. N., Asala, T., Nwonu, E. J., Njoku, M. O., Asala, O. O., Salami, S. A., & Mbachu, N. A. (2023) · Veterinary Vaccine · doi:10.1016/j.vetvac.2023.100013 · Cited by 11
Zhang, C., Wang, L., Xu, C., Xu, H., & Wu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1079924 · Cited by 11
Francis, M. E., Jansen, E. B., Yourkowski, A., Selim, A., Swan, C. L., MacPhee, B. K., Thivierge, B. M., Buchanan, R. M., Lavender, K. J., Darbellay, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41761-1 · Cited by 11
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ
Newey, A., Yu, L., Barber, L. J., Choudhary, J. S., Bassani‐Sternberg, M., & Gerlinger, M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0121 · Cited by 11
Enhancing antigenic peptide discovery: Improved MHC-I binding prediction and methodology
Giziński, S., Preibisch, G., Kucharski, P., Tyrolski, M., Rembalski, M., Grzegorczyk, P., & Gambin, A. (2024) · Methods · doi:10.1016/j.ymeth.2024.01.016 · Cited by 11
Shahbazy, M., Ramarathinam, S. H., Li, C., Illing, P. T., Faridi, P., Croft, N. P., & Purcell, A. W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae087 · Cited by 11
Breast cancer, viruses, and human leukocyte antigen (HLA)
James, L. M., & Georgopoulos, A. P. (2024) · Scientific Reports · doi:10.1038/s41598-024-65707-9 · Cited by 11
Immunopeptidomics Mapping of Listeria monocytogenes T Cell Epitopes in Mice
Gul, A., Pewe, L. L., Willems, P., Mayer, R. L., Théry, F., Asselman, C., Aernout, I., Verbeke, R., Eggermont, D., Moortel, L. V., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100829 · Cited by 11
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.